Early Environments, Lasting Effects: Air Pollution, Microbes, and Respiratory Infection Risk in Children

Olivia H Rice1, Lisa A Miller1,2

  • 1National Biomedical Research Institute, University of California Davis, Davis, CA, USA.

Pediatric Pulmonology
|August 19, 2026
PubMed

Insights

Environmental factors like air pollution and microbes significantly impact children's respiratory health. Improving air quality and supporting a healthy early-life microbiome can reduce infection risks and promote lifelong lung health.

Area of Science:

  • Environmental Health
  • Pediatric Pulmonology
  • Immunology

Background:

  • Respiratory tract infections are a major cause of illness and death in children globally.
  • Early-life infections can lead to lasting lung and immune system problems.
  • Environmental exposures play a critical role in children's susceptibility to respiratory infections.

Purpose of the Study:

  • To review the evidence linking environmental factors to respiratory infections in children.
  • To explore the impact of air pollution and the respiratory microbiome on pediatric airway health.
  • To understand how environmental exposures influence infection risk and long-term lung function.

Main Methods:

  • This narrative review synthesized findings from epidemiological and experimental studies.
  • Examined the effects of ambient and indoor air pollution on respiratory infections.
  • Investigated the role of the respiratory microbiome and microbial exposures in immune development and infection susceptibility.

Main Results:

  • High concentrations of air pollution are linked to increased frequency of upper and lower respiratory tract infections in children.
  • Exposure to pollutants like PM2.5 impairs lung epithelial barriers, causes oxidative stress, inflammation, and weakens immune cell function.
  • A balanced respiratory microbiome is crucial for immune defense, while dysbiosis increases infection and chronic disease risk.
  • Exposure to diverse microbes, including fungi, may offer protection against respiratory illnesses.

Conclusions:

  • Environmental factors, including air quality and the microbiome, significantly influence children's respiratory infection risk.
  • Interventions targeting air quality improvement and microbiome support in early life are vital.
  • These strategies can mitigate respiratory infections and foster long-term lung health in children.

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...